Why is Berkshire Hathaway’s cash pile surging?
How is the government shutdown affecting air travel?
What caused Chipotle’s stock to tumble recently?
Why did Amazon’s stock hit a new record?
How will the Fed’s upcoming rate decisions impact markets?
What’s driving the surge in China EV maker sales?
Why are SNAP benefits funding disputes intensifying?
Neurocrine Biosciences Beats Estimates But Wall Street Punishes The Stock
247wallst.com/investing/2025/10/28/neurocrine-biosciences-beats-estimates-but-wall-street-punishes-the-stock
Key Points
Neurocrine Biosciences posts standout Q3 beat as INGREZZA and CRENESSITY drive 28% product sales growth.
Neurocrine Biosciences pipeline momentum builds with Phase 3 schizophrenia trial and new MDD program progress.
The right cash back credit card…
This story appeared on 247wallst.com, 2025-10-29 00:03:08.